Protective efficacy of GMAI-02, a cDNA-derived inactivated hepatitis A vaccine, against HM175/mp7 challenge in interferon-receptor-deficient mice.

Saved in:
Bibliographic Details
Title: Protective efficacy of GMAI-02, a cDNA-derived inactivated hepatitis A vaccine, against HM175/mp7 challenge in interferon-receptor-deficient mice.
Authors: Chung YJ; R&D Center, Genematrix, Inc., Seongnam-si, Gyeonggi-do, Republic of Korea., Oh HS; R&D Center, Genematrix, Inc., Seongnam-si, Gyeonggi-do, Republic of Korea., Kim SO; R&D Center, Genematrix, Inc., Seongnam-si, Gyeonggi-do, Republic of Korea., Hong SP; R&D Center, Genematrix, Inc., Seongnam-si, Gyeonggi-do, Republic of Korea. Electronic address: sunphong@genematrix.net.
Source: Virology [Virology] 2026 Jun; Vol. 619, pp. 110883. Date of Electronic Publication: 2026 Mar 18.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0341 (Electronic) Linking ISSN: 00426822 NLM ISO Abbreviation: Virology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-0341
DOI:10.1016/j.virol.2026.110883